ZA983327B - Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine. - Google Patents
Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine.Info
- Publication number
- ZA983327B ZA983327B ZA9803327A ZA983327A ZA983327B ZA 983327 B ZA983327 B ZA 983327B ZA 9803327 A ZA9803327 A ZA 9803327A ZA 983327 A ZA983327 A ZA 983327A ZA 983327 B ZA983327 B ZA 983327B
- Authority
- ZA
- South Africa
- Prior art keywords
- aqueous solvent
- virus type
- herpes virus
- solvent based
- subunit vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/813—Viral vaccine for bovine species, e.g. cattle
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4417297P | 1997-04-23 | 1997-04-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA983327B true ZA983327B (en) | 1999-10-21 |
Family
ID=21930892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9803327A ZA983327B (en) | 1997-04-23 | 1998-04-21 | Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine. |
Country Status (15)
Country | Link |
---|---|
US (1) | US6270800B1 (zh) |
EP (1) | EP0873752B1 (zh) |
JP (1) | JPH10316586A (zh) |
CN (1) | CN1196931A (zh) |
AR (1) | AR012009A1 (zh) |
AT (1) | ATE262324T1 (zh) |
AU (1) | AU713639B2 (zh) |
BR (1) | BR9801435A (zh) |
CA (1) | CA2229430A1 (zh) |
DE (1) | DE69822542T2 (zh) |
DK (1) | DK0873752T3 (zh) |
ES (1) | ES2216242T3 (zh) |
NZ (1) | NZ330251A (zh) |
PT (1) | PT873752E (zh) |
ZA (1) | ZA983327B (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6855316B1 (en) * | 1994-02-14 | 2005-02-15 | University Of Hawaii | Baculovirus produced Plasmodium falciparum vaccine |
ES2368987T3 (es) * | 1999-02-05 | 2011-11-24 | Alk-Abelló A/S | Sistema de administración a través de las mucosas. |
KR20010003853A (ko) * | 1999-06-25 | 2001-01-15 | 박호군 | 경구용 백신으로 사용할 수 있는 알긴산염 마이크로스피어 및그 제조방법 |
US7037681B2 (en) * | 2000-02-08 | 2006-05-02 | University Of Hawaii | Plasmodium falciparum merozoite surface protein-1 malaria produced in transgenic plants |
US20030100106A1 (en) * | 2000-02-08 | 2003-05-29 | Chang Sandra P. | Baculovirus produced Plasmodium falciparum vaccine |
JP4370451B2 (ja) * | 2001-09-28 | 2009-11-25 | 大塚製薬株式会社 | 医薬組成物 |
WO2006063030A1 (en) * | 2004-12-08 | 2006-06-15 | Speaker Tycho J | Microencapsulation product and process |
CN104302279A (zh) * | 2012-05-10 | 2015-01-21 | 聚和国际股份有限公司 | 用于制备微胶囊的组合物及用其所制得的药物 |
WO2014193908A1 (en) | 2013-05-28 | 2014-12-04 | Capsulent | Products containing charged polymer complex microcapsules and method of use |
CN107973840A (zh) * | 2017-01-13 | 2018-05-01 | 浙江海隆生物科技有限公司 | CHO细胞表达牛传染性病气管炎病毒gD蛋白及其亚单位疫苗的制备和应用 |
CN112180089A (zh) * | 2020-09-21 | 2021-01-05 | 黑龙江八一农垦大学 | 一种牛疱疹病毒i型抗体阻断elisa检测方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5151267A (en) * | 1988-07-15 | 1992-09-29 | University Of Saskatchewan | Bovine herpesvirus type 1 polypeptides and vaccines |
US5585264A (en) * | 1988-07-15 | 1996-12-17 | University Of Saskatchewan | Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides |
US5462734A (en) * | 1990-11-02 | 1995-10-31 | Wisconsin Alumni Research Foundation | Bovine herpesvirus vaccine and method of using same |
ATE235959T1 (de) * | 1994-04-15 | 2003-04-15 | Univ Temple | Methode zum einkapseln mittels eines wässrigen lösungsmittels und mikrokapseln |
US5686113A (en) * | 1995-03-21 | 1997-11-11 | Temple University Of The Commonwealth System Of Higher Education | Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses |
-
1998
- 1998-04-14 DK DK98302863T patent/DK0873752T3/da active
- 1998-04-14 ES ES98302863T patent/ES2216242T3/es not_active Expired - Lifetime
- 1998-04-14 EP EP19980302863 patent/EP0873752B1/en not_active Expired - Lifetime
- 1998-04-14 AT AT98302863T patent/ATE262324T1/de not_active IP Right Cessation
- 1998-04-14 PT PT98302863T patent/PT873752E/pt unknown
- 1998-04-14 DE DE1998622542 patent/DE69822542T2/de not_active Expired - Fee Related
- 1998-04-21 AU AU63511/98A patent/AU713639B2/en not_active Ceased
- 1998-04-21 ZA ZA9803327A patent/ZA983327B/xx unknown
- 1998-04-21 US US09/063,676 patent/US6270800B1/en not_active Expired - Lifetime
- 1998-04-22 CN CN98107316A patent/CN1196931A/zh active Pending
- 1998-04-22 AR ARP980101867 patent/AR012009A1/es not_active Application Discontinuation
- 1998-04-22 NZ NZ330251A patent/NZ330251A/en unknown
- 1998-04-23 JP JP11392798A patent/JPH10316586A/ja active Pending
- 1998-04-23 BR BR9801435A patent/BR9801435A/pt not_active IP Right Cessation
- 1998-04-23 CA CA 2229430 patent/CA2229430A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DK0873752T3 (da) | 2004-05-10 |
US6270800B1 (en) | 2001-08-07 |
AU6351198A (en) | 1998-11-12 |
ES2216242T3 (es) | 2004-10-16 |
ATE262324T1 (de) | 2004-04-15 |
PT873752E (pt) | 2004-07-30 |
EP0873752A2 (en) | 1998-10-28 |
AU713639B2 (en) | 1999-12-09 |
AR012009A1 (es) | 2000-09-13 |
JPH10316586A (ja) | 1998-12-02 |
NZ330251A (en) | 1998-11-25 |
EP0873752A3 (en) | 2001-02-07 |
EP0873752B1 (en) | 2004-03-24 |
DE69822542D1 (de) | 2004-04-29 |
DE69822542T2 (de) | 2004-08-05 |
CA2229430A1 (en) | 1998-10-23 |
BR9801435A (pt) | 2000-01-11 |
CN1196931A (zh) | 1998-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL181468A0 (en) | E2 subunit vaccine comprising recombinant pestivirus e2 protein | |
EP0621339A3 (en) | Immunogenic human influenza a virus haemagglutinin polypeptides. | |
HU9800802D0 (en) | Influenza vaccine | |
ZA975889B (en) | HIV envelope polypeptides and vaccine. | |
IL136446A0 (en) | Vaccine | |
AU4653989A (en) | Biologically competent, virus inactivated albumin | |
HUP0000589A3 (en) | Aqueous formulations of peptides | |
HK1030768A1 (en) | Cyclic amino acids and derivatives thereof useful as pharmaceutical agents. | |
ZA983327B (en) | Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine. | |
AU3328900A (en) | Influenza virus hemagglutinin-binding peptides | |
GB9826069D0 (en) | HIV vaccine | |
HUP9701586A3 (en) | Improved inactivated vaccines | |
EP0366238A3 (en) | Influenza vaccinal polypeptides | |
IL148191A0 (en) | Recombinant subunit vaccine | |
AU7915398A (en) | An influenza enveloped dna vaccine | |
NZ230459A (en) | Method of purifying the ha2 subunit of the influenza virus ha protein | |
AU6127498A (en) | Msh-receptor subtype selective cyclic peptides | |
GB9704977D0 (en) | FIV vaccine | |
GB9702990D0 (en) | Virus vaccine | |
IL136230A0 (en) | An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes | |
GB9725241D0 (en) | Hiv vaccine | |
GB9703202D0 (en) | HIV vaccine | |
AU3930895A (en) | Viral preparations, immunogens, and vaccines | |
BR1100968A (pt) | Formulação de vacina de subunidade | |
GB9603322D0 (en) | Viral preparations,immunogens and vaccines |